Results 161 to 170 of about 68,398 (251)

Itolizumab – a humanized anti-CD6 monoclonal antibody with a better side effects profile for the treatment of psoriasis [PDF]

, 2015
Roshni Menon, Brinda G David Department of Dermatology, Venereology and Leprosy, Sri Venkateshwaraa Medical College Hospital and Research Centre, Ariyur, Pondicherry, India Abstract: Management of psoriasis is a challenge to the treating physician. The
David BG,, Menon R
core  

Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination. [PDF]

Int J Hematol, 2022
Inaba T, Okumura K, Maekura C, Muramatsu A, Kobayashi T, Kuroda J, Nukui Y.   +6 more
europepmc   +1 more source

First‐Line Treatment of IGHV‐Unmutated Chronic Lymphocytic Leukemia: A Network Meta‐Analysis of Targeted and Chemoimmunotherapy Regimens

European Journal of Haematology, Volume 117, Issue 2, Page 375-383, August 2026.
ABSTRACT Immunoglobulin heavy chain variable region‐unmutated (IGHV‐U) chronic lymphocytic leukemia (CLL) represents a biologically aggressive subgroup with limited responsiveness to chemoimmunotherapy (CIT). To clarify the comparative effectiveness of available frontline options, we conducted a comprehensive Bayesian network meta‐analysis of ...
Santino Caserta, Enrica Antonia Martino, Danilo Lofaro, Ernesto Vigna, Antonella Bruzzese, Francesco Mendicino, Maria Eugenia Alvaro, Caterina Labanca, Eugenio Lucia, Virginia Olivito, Nicola Amodio, Fortunato Morabito, Valter Gattei, Massimo Gentile   +13 more
wiley   +1 more source

Correction to: Patients with B-cell lymphoma receiving anti-CD20 monoclonal antibody-containing chemotherapies and seroreactive patterns in response to COVID-19 vaccination. [PDF]

Int J Hematol, 2022
Inaba T, Okumura K, Maekura C, Muramatsu A, Kobayashi T, Kuroda J, Nukui Y.   +6 more
europepmc   +1 more source

Anti-CD20 Monoclonal Antibody B001 [PDF]

, 2020
openaire   +1 more source

Bone Marrow Pathology in Cold Agglutinin‐Mediated Autoimmune Hemolytic Anemia: A Study of 56 Cases

European Journal of Haematology, Volume 117, Issue 2, Page 384-395, August 2026.
ABSTRACT Cold agglutinin disease (CAD) is a rare form of autoimmune hemolytic anemia (AIHA). CAD occurs in the context of a small clonal B‐cell lymphoproliferation restricted to blood and/or bone marrow (BM), without overt or extramedullary lymphoma. The WHO‐HAEM5 introduced a description of the CAD‐associated lymphoproliferative disorder (CAD‐LPD) in ...
Anne‐Marie L. Becking, Sophie J. Bernelot Moens, Marie José Kersten, Femke V. M. Mulder, Steven T. Pals, Lianne Koens, Josephine M. I. Vos   +6 more
wiley   +1 more source

Rituximab: historia, farmacología y perspectivas Rituximab: history, pharmacology and perspectives

Revista Cubana de Hematología, Inmunología y Hemoterapia, 2010
El rituximab integra la primera generación de anticuerpos monoclonales anti CD20 que se utiliza como terapia biológica en los síndromes linfoproliferativos crónicos de estirpe B, en enfermedades autoinmunes y en otras entidades donde hay proliferación de
Edgardo E. Espinosa Estrada, Luis G. Ramón Rodríguez, Lissete Izquierdo Cano, Onel M. Ávila Cabrera, Carlos Hernández Padrón, Edgardo Espinosa Martínez   +5 more
doaj  

Effects of a Fully Humanized Type II Anti-CD20 Monoclonal Antibody on Peripheral and CNS B Cells in a Transgenic Mouse Model of Multiple Sclerosis. [PDF]

Int J Mol Sci, 2022
Tacke S, Chunder R, Schropp V, Urich E, Kuerten S.   +4 more
europepmc   +1 more source

From Time‐Limited Therapy to Treatment‐Free Observation: The Evolving Role of MRD in CLL Management

European Journal of Haematology, Volume 117, Issue 2, Page 305-319, August 2026.
ABSTRACT The integration of measurable residual disease (MRD) into the management of chronic lymphocytic leukemia (CLL) has emerged as a major advance in risk stratification and trial design, particularly in the context of time‐limited, targeted regimens.
Enrica Antonia Martino, Santino Caserta, Ernesto Vigna, Antonella Bruzzese, Maria Eugenia Alvaro, Nicola Amodio, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Francesco Mendicino, Mamdouh Skafi, Valter Gattei, Fortunato Morabito, Massimo Gentile   +13 more
wiley   +1 more source

Fatal Outcome of COVID-19 Relapse in a Fully Vaccinated Patient with Non-Hodgkin Lymphoma Receiving Maintenance Therapy with the Anti-CD20 Monoclonal Antibody Obinutuzumab: A Case Report. [PDF]

Vaccines (Basel), 2022
Calò F, Onorato L, Pisaturo M, Pinto A, Alessio L, Monari C, Minichini C, Arcamone M, Di Fraia A, Atripaldi L, Tiberio C, Coppola N.   +11 more
europepmc   +1 more source